ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Alzheimer’s disease

Repurposed cancer drug to enter Phase I trials for Alzheimer’s disease this year

Repurposed cancer drug to enter Phase I trials for Alzheimer’s disease this year

May 14, 2013 8:10 am by | 0 Comments

In the world of Alzheimer’s disease drugs, the past year has been marked by disappointing Phase 3 clinical trial results for a handful of much-anticipated antibody drugs.But the failure of ... Read more
Potential disease-altering drug for Alzheimer’s draws $6.4 million, with IND planned for 2014

Potential disease-altering drug for Alzheimer’s draws $6.4 million, with IND planned for 2014

May 6, 2013 1:51 pm by | 0 Comments

A preclinical drug aimed at preventing misfolded proteins from getting tangled in the brain and potentially causing neurodegenerative disease has drawn another $6.4 million from investors.The latest round for NeuroPhage ... Read more
Lilly to acquire 2 radiopharmaceutical tracers from Siemens to grow Alzheimer’s portfolio

Lilly to acquire 2 radiopharmaceutical tracers from Siemens to grow Alzheimer’s portfolio

April 17, 2013 8:02 am by | 0 Comments

CHICAGO, April 17 (Reuters) - In a move to shore up its lead in Alzheimer's diagnostics, Eli Lilly and Co on Wednesday said it will acquire two imaging agents from ... Read more
Researcher building a dream team of visionaries to crack human brain’s code

Researcher building a dream team of visionaries to crack human brain’s code

April 8, 2013 8:04 am by | 2 Comments

WASHINGTON (Reuters) - To crack the code of the human brain, Cori Bargmann figures it's best to keep an open mind.As one of two leaders of a scientific "dream team" ... Read more
Alzheimer’s death rates outpace other illnesses

Alzheimer’s death rates outpace other illnesses

April 1, 2013 6:19 am by | 0 Comments

Deaths from strokes, heart attacks and cancer declined significantly between 2000 and 2010, according to the Centers for Disease Control and Prevention, while death from Alzheimer's increased significantly. ... Read more
Lundbeck, Otsuka to work on new Alzheimer’s disease treatment

Lundbeck, Otsuka to work on new Alzheimer’s disease treatment

March 26, 2013 3:40 am by | 0 Comments

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had agreed to work with Japan's Otsuka to develop and commercialize an Alzheimer's drug. The agreement covers its Lu ... Read more
U.S. deaths from Alzheimer’s growing, data shows

U.S. deaths from Alzheimer’s growing, data shows

March 19, 2013 11:45 am by | 0 Comments

WASHINGTON (Reuters) - Deaths and the risk of dying from Alzheimer's disease have risen significantly in the United States during the last decade, according to two reports released on Tuesday.The ... Read more
Three East Coast startups move to final round in health division at SxSW accelerator

Three East Coast startups move to final round in health division at SxSW accelerator

March 12, 2013 2:15 am by | 1 Comments

Three West Coast investors picked three East Coast healthcare startups to move on to the final round of the SxSW health accelerator in Austin on Monday.NeuroTrack, Docphin and Careport Health ... Read more
Weight loss simulator, hand-held counterfeit drug detector among HHS’ best innovations

Weight loss simulator, hand-held counterfeit drug detector among HHS’ best innovations

March 5, 2013 8:42 am by | 0 Comments

In an effort to showcase that government entities are doing what they can to encourage innovation too, the U.S. Department of Health and Human Services (HHS) is inviting the public ... Read more
Psychiatrist hopes book will help win $30M to test potential Alzheimer’s drug

Psychiatrist hopes book will help win $30M to test potential Alzheimer’s drug

February 24, 2013 3:13 am by | 1 Comments

A retired psychology professor is hoping his new book about methanesulfonyl fluoride will gain enough attention to fund new trials to determine the compound's potential for treating Alzheimer's. The compound ... Read more
Baby brains could presage Alzheimer’s or other adulthood diseases, researchers say

Baby brains could presage Alzheimer’s or other adulthood diseases, researchers say

February 21, 2013 3:00 am by | 0 Comments

CHAPEL HILL -- Brain images from newborns are giving scientists a glimpse of the future -- not just into the lives of their tiny subjects but also paths to treatment ... Read more
After failed trials, J&J pivots to early-stage Alzheimer’s

After failed trials, J&J pivots to early-stage Alzheimer’s

February 13, 2013 7:55 am by | 0 Comments

CHICAGO (Reuters) - A little over a year ago, Dr. Husseini Manji, global head of neuroscience drug development at Johnson & Johnson, predicted that brain researchers were on the cusp ... Read more
FDA outlines path to test Alzheimer’s drugs earlier

FDA outlines path to test Alzheimer’s drugs earlier

February 7, 2013 5:15 pm by | 0 Comments

CHICAGO (Reuters) - Proposed U.S. guidelines may make it easier for drug companies to test Alzheimer's treatments in people at an earlier stage, when scientists think they may have the ... Read more
Alzheimer’s to triple by 2050 as baby boomers age

Alzheimer’s to triple by 2050 as baby boomers age

February 6, 2013 5:18 pm by | 1 Comments

CHICAGO (Reuters) - The number of U.S. residents aged 65 and older living with Alzheimer's disease is expected to nearly triple to 13.8 million by 2050 as aging baby boomers ... Read more
Alzheimer’s and Parkinson’s not contagious: study

Alzheimer’s and Parkinson’s not contagious: study

February 6, 2013 5:09 pm by | 0 Comments

NEW YORK (Reuters Health) - Despite concerns that faulty brain proteins could be transferred from person to person by treatments involving human fluids and tissues, a new study finds no ... Read more